In summary, it was determined that CCO at a dose of 300 mg/kg does not cause liver or kidney damage; and in diabetic rats, it reduced ALT, AST, and BUN levels, and had antidiabetic and anti-inflammatory effects. This evidence concerns the gene GPT and central core myopathy.